Skip to main content
Log in

The Effect of Gastric pH on the Absorption of Controlled-Release Theophylline Dosage Forms in Humans

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The bioavailability of three marketed controlled-release dosage forms and a reference solution of theophylline was studied in eight subjects with normal gastric fluid acidity and seven subjects who were achlorhydric. Gastric pH was monitored with a Heidelberg capsule. One of the controlled-release dosage forms dissolved more rapidly in vitro when exposed to acid conditions, one dissolved more rapidly in pH 7.5 media, and the third dissolved at a rate independent of pH. Using a crossover design, each subject received each dosage form twice. Blood was sampled for up to 47 hr after each dose, and serum was assayed for theophylline by HPLC. The product which dissolved more rapidly under acid conditions in vitro exhibited a 3 hr longer T max in the achlorhydrics compared to the normal subjects. The product which dissolved more rapidly in the pH 7.5 media exhibited a relatively higher AUC(0–∞) in the achlorhydric subjects than in normal subjects after the AUC data were normalized for clearance differences between the two subject groups. The in vivo bioavailability of these dosage forms could be related to the in vitro dissolution characteristics for some parameters. However, with the exception of the mean T max values, the mean bioavailability parameters differed by less than 20% between the two subject groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. H. Ogata, N. Aoyagi, N. Kaniwa, M. Koibuchi, T. Shibazaki, A. Ejima, S. Tsuji, and Y. Kawazu. Bioavailability of diazepam from uncoated tablets in humans. Its correlation with the dissolution rates of the tablets. Int. J. Clin. Pharmacol. Ther. Toxicol. 20:159–165 (1982).

    Google Scholar 

  2. H. Ogata, N. Aoyagi, N. Kaniwa, M. Koibuchi, T. Shibazaki, A. Ejima, S. Tsuji, and Y. Kawazu. Bioavailability of diazepam from uncoated tablets in humans. Effect of gastric fluid acidity. Int. J. Clin. Pharmacol. Ther. Toxicol. 20:166–170 (1982).

    Google Scholar 

  3. V. K. Prasad, V. P. Shah, P. Knight, H. Malinowski, B. E. Cabana, and M. C. Meyer. Importance of media selection in establishment of in vitro-in vivo relationships for quinidine gluconate. Int. J. Pharm. 13:1–7 (1983).

    Google Scholar 

  4. R. R. Berardi, J. B. Dressman, G. H. Elta, and G. J. Szpunar. Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets. Biopharm Drug Dispos. 9:337–347 (1988).

    Google Scholar 

  5. V. I. Vashi and M. C. Meyer. The effect of pH on the in vitro dissolution and the in vivo absorption of controlled-release theophylline in dogs. J. Pharm. Sci. 77(9):760–764 (1988).

    Google Scholar 

  6. P. M. Christiansen. The incidence of achlorhydria and hypochlorhydria in healthy subjects and patients with diseases. Scand. J. Gastroent. 3:497–508 (1968).

    Google Scholar 

  7. M. Bins, P. I. C. J. Burgers, S. G. M. Selbach, Th. B. van Wettum, C. B. H. W. Lamers, and J. H. M. van Tongeren. Prevalence of achlorhydria in a normal population and its relation to serum gastrin. Hepato. Gastroenrol. 31:41–43 (1984).

    Google Scholar 

  8. Heidelberg pH Capsule System, Training and Instruction Manual, 5th ed., Heidelberg International, Norcross, GA, 1985.

  9. A. M. Connell and T. E. Waters. Assessment of gastric function by pH telemetering capsule. Lancet 2:227–230 (1964).

    Google Scholar 

  10. W. C. Watson and E. Paton. Studies on intestinal pH by radiotelemetering. Gut 6:606–612 (1965).

    Google Scholar 

  11. D. R. Yarbrough, J. C. McAlhany, N. Cooper, and M. G. Weidner. Evaluation of the Heidelberg pH capsule. Am. J. Surg. 117:185–192 (1969).

    Google Scholar 

  12. J. B. Dressman and G. L. Amidon. Radiotelemetric method for evaluating enteric coatings in vivo. J. Pharm. Sci. 73:935–938 (1984).

    Google Scholar 

  13. C. Y. Lui, G. L. Amidon, R. R. Berardi, D. Fleisher, C. Youngberg, and J. B. Dressman. Comparison of gastrointestinal pH in dogs and humans: Implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 75:271–273 (1986).

    Google Scholar 

  14. M. M. Wolfe and A. H. Soll. The physiology of gastric acid secretion. N. Engl. J. Med. 319(26):1707–1715 (1988).

    Google Scholar 

  15. H. N. Farrish and W. A. Wargin. Separation and quantitation of theophylline and paraxanthine by reversed-phase liquid chromatography. Clin. Chem. 26:524–525 (1980).

    Google Scholar 

  16. J. Wagner. Fundamentals of Clinical Pharmacokinetics, Drug Intelligence, Hamilton, IL, 1975, p. 175.

    Google Scholar 

  17. K. S. Albert and R. B. Smith, In K. S. Albert (ed.), Drug Absorption and Disposition: Statistical Considerations, American Pharmaceutical Association, Washington, DC, 1980, pp. 87–114.

    Google Scholar 

  18. A. Karim. Theophylline with food: Theo-24. Am. Pharm. NS25:132–133 (1985).

    Google Scholar 

  19. R. Penagini, R. C. Spiller, J. J. Misiewicz, P. G. Frost, and D. B. A. Silk. Effect of cholecystectomy on mouth-to-cecum transit of a liquid meal. Digest Dis. Sci. 33(1):19–22 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, M.C., Straughn, A.B., Jarvi, E.J. et al. The Effect of Gastric pH on the Absorption of Controlled-Release Theophylline Dosage Forms in Humans. Pharm Res 10, 1037–1045 (1993). https://doi.org/10.1023/A:1018923008579

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018923008579

Navigation